Medical/Safety Monitoring

The Therapeutics Development Network Coordinating Center can provide coverage and coordination for the review and reporting of serious adverse events that may occur during the course of cystic fibrosis clinical studies.

1 min read

In this article

Medical Monitoring

Medical monitoring is provided by an on-call team of board-certified pulmonologists, trained in cystic fibrosis clinical trial conduct and safety monitoring. The Therapeutic Development Network Coordinating Center oversees the medical monitoring program.

Serious Adverse Events Monitoring

In addition to serious adverse event (SAE) monitoring, the medical monitors can review adverse events listings on a regular basis to identify any potential events.

Contact the Center

To discuss how the Therapeutic Development Network Coordinating Center can best support your study, please contact tdncc@seattlechildrens.org.

Share this article